Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Cell Therapy Catapult Launches New CAR-T Company Targeting Solid Tumors

This article was originally published in Scrip

Executive Summary

The Cell Therapy Catapult (CTC), a UK-based organization focused on growth of the UK cell and gene therapy sector, is teaming up with the University of Birmingham and Cancer Research UK to develop a new generation chimeric antigen receptor T-Cell (CAR-T) immune-oncology therapy for solid tumors.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

SC064149

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

All set! This Question has been sent to my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel